Related Experiment Video
Updated: Jan 30, 2026

Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin
Published on: November 1, 2019
Curcumin-selenium nanoparticles: A promising approach in disease prevention and treatment
Sahar Ghoflchi1, Sercan Karav2, Hossein Hosseini1
1Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract:
Curcumin, the primary active ingredient from turmeric's rhizome, and selenium, a vital human element, have received significant scientific attention in medical research. The combination of curcumin and selenium has been considered an emerging approach to preventing and treating diseases due to their ability to reduce oxidative stress, regulate inflammation, and enhance the immune system. The use of nanotechnology, especially in the form of curcumin-selenium nanoparticles (CurSeNPs), has provided a novel solution to overcome the limitations of the use of curcumin and selenium, such as the low bioavailability of curcumin and the toxicity of selenium at high doses. This review aims to explore the research on the effects of CurSeNPs on various diseases and assess their therapeutic potential. This review aims to evaluate previous studies exploring the effects of Cur-SeNPs on various diseases.
More Related Videos
06:36PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP
Published on: April 9, 2013
14:10Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Coronary Artery Disease IV: Preventive Measures
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Cancer Prevention
Some...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents